Chemotherapy and autophagy-mediated cell death in pancreatic cancer cells

Pancreatology

Volumn 12, Issue 1, 2012, Pages 1-7

  Ropolo, Alejandro ^a   Bagnes, Claudia I ^a   Molejon, Maria I ^a   Re, Andrea Lo ^a   Boggio, Veronica ^a   Gonzalez, Claudio D ^a   Vaccaro, Maria I ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Autophagy; Chemotherapeutic drugs; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOPHAGY PROTEIN 5; BECLIN 1; CAPECITABINE; CARDIAC GLYCOSIDE; CASPASE; FLUOROURACIL; GEMCITABINE; IRINOTECAN; K RAS PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; OBATOCLAX; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BNIP3; PROTEIN KINASE B; PROTEIN KINASE C DELTA; REACTIVE OXYGEN METABOLITE; SORAFENIB; VORINOSTAT;

AUTOPHAGY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL DEATH; CELL SURVIVAL; DRUG POTENTIATION; ENZYME ACTIVATION; GENE MUTATION; HUMAN; HYPOXIA; IN VITRO STUDY; NONHUMAN; ONCOGENE H RAS; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84862186414     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2011.11.003     Document Type: Review

References (67)

1. Klionsky DJ, Cregg JM, Dunn Emr WA, Emr Jr SD, Sakai Y, Sandoval IV, et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell 2003;5: 539-45. (Pubitemid 37243044)
2. Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2009;22:1-8.
3. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008;451:1069-75. (Pubitemid 351317450)
4. Høyer-Hansen M, Jäättelä M. Autophagy: an emerging target for cancer therapy. Autophagy 2008;4:574-80.
5. Toth S, Nagy K, Palfia Z, Rez G. Cellular autophagic capacity changes during azaserine-induced tumour progression in the rat pancreas: up-regulation in all premalignant stages and down-regulation with loss of cycloheximide sensitivity of segregation along with malignant transformation. Cell Tissue Res 2002;309:409-16. (Pubitemid 35000495)
6. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003;112:1809-20. (Pubitemid 38063704)
7. Chen N, Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim Biophys Acta 2009;1793:1516-23.
8. Levine B. Cell biology: autophagy and cancer. Nature 2007;446:745-7. (Pubitemid 46582063)
9. Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007;7:961-7. (Pubitemid 350165856)
10. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
11. Jaffee EM, Hruban RH, Canto M, Kern SE. Focus on pancreas cancer. Cancer Cell 2002;2:25-8. (Pubitemid 41043985)
12. Buchler P, Reber HA, Lavey RS, Tomlinson J, Büchler MW, Friess H, et al. Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model. J Surg Res 2004;120:295-303. (Pubitemid 38834199)
13. Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res 2000;60:6201-7.
14. Esumi H, Izuishi K, Kato K, Hashimoto K, Kurashima Y, Kishimoto A, et al. Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 50-AMP-activated protein kinase-dependent manner. J Biol Chem 2002;277: 32791-8. (Pubitemid 34984788)
15. Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, Kojima M, et al. A autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 2008;99:1813-9.
16. DeNardo DG, Johansson M, Coussens LM. Inflaming gastrointestinal oncogenic programming. Cancer Cell 2008;14:7-9. (Pubitemid 351885501)
17. Abe R, Yamagishi S. AGE-RAGE system and carcinogenesis. Curr Pharm Des 2008;14:940-5. (Pubitemid 351753280)
18. Arumugam T, Simeone DM, Van GK, Logsdon CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 2005;11:5356-64. (Pubitemid 41060808)
19. Kang R, Tang D, Schapiro NE, Livesey KM, Farkas A, Loughran P, et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 2009;16:1-11.
20. Kewley RJ, Whitelaw ML, Chapman-Smith A. The mammalian basic helixloop- helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol 2004;36:189-204. (Pubitemid 37487755)
21. Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, Macleod KF. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 2007;27:6229-42. (Pubitemid 47326709)
22. Azad MB, Chen Y, Henson ES, Cizeau J, McMillan-Ward E, Israels SJ, et al. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008;4:195-204. (Pubitemid 351231183)
23. Burton TR, Gibson SB. The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ 2009;16:515-23.
24. Okami J, Simeone DM, Logsdon CD. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res 2004;64:5338-46. (Pubitemid 39006554)
25. Mahon PC, Baril P, Bhakta V, Chelala C, Caulee K, Harada T, et al. S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. Cancer Res 2007;67:6786-95. (Pubitemid 47105526)
26. Abe T, Toyota M, Suzuki H, Murai M, Akino K, Ueno M, et al. Upregulation of BNIP3 by 5-aza-2'-deoxycytidine sensitizes pancreatic cancer cells to hypoxiamediated cell death. J Gastroenterol 2005;40:504-10. (Pubitemid 40823286)
27. Farrall AL, Whitelaw ML. The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element. Oncogene 2009;28:3671-80.
28. Mehta K, Fok J, Miller FR, Koul D, Sahin AA. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 2004;10:8068-76. (Pubitemid 39587548)
29. Elsasser HP, MacDonald R, Dienst M, Kern HF. Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells. Eur J Cell Biol 1993;61:321-8. (Pubitemid 23307544)
30. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 2003;63:8614-22. (Pubitemid 38064035)
31. Akar U, Ozpolat B, Mehta K, Fok J, Kondo Y, Lopez-Berestein G. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells. Mol Cancer Res 2007;5:241-9. (Pubitemid 46569775)
32. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004;23:2891-906. (Pubitemid 38638851)
33. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011;25:460-70.
34. Elgendy M, Sheridan C, Brumatti G, Martin SJ. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 2011;42:23-35.
35. Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev 2011;25:717-29.
36. Mariño G, Martins I, Kroemer G. Autophagy in Ras-induced malignant transformation: fatal or vital? Mol Cell 2011;42:1-3.
37. Guan J, Stromhaug PE, George MD, Habibzadegah-Tari P, Bevan A, Dunn Jr WA, et al. Cvt18/Gsa12 is required for cytoplasm-to-vacuole transport, pexophagy, and autophagy in Saccharomyces cerevisiae and Pichia pastoris. Mol Biol Cell 2001;12:3821-38. (Pubitemid 34001076)
38. Proikas-Cezanne T, Waddell S, Gaugel A, Frickey T, Lupas A, Nordheim A. WIPI-1alpha (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy. Oncogene 2004;23:9314-25. (Pubitemid 40069664)
39. Proikas-Cezanne T, Robenek H. Freeze-fracture replica immunolabelling reveals human WIPI-1 and WIPI-2 as membrane proteins of autophagosomes. J Cell Mol Med 2011;15:2007-10.
40. Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFkB activation in the tumor stromal microenvironment. Cell Cycle 2010;9: 3515-33.
41. Lisanti MP, Martinez-Outschoorn UE, Chiavarina B, Pavlides S, Whitaker- Menezes D, Tsirigos A, et al. Understanding the "lethal" drivers of tumorstroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment. Cancer Biol Ther 2010;10:537-42.
42. Kim EJ, Simeone DM. Advances in pancreatic cancer. Curr Opin Gastroenterol 2011;27:460-6.
43. Von Hoff DD, Ramanathan RK, Borad MJ, Laheru DA, Smith LS, Wood TE, et al. Gemcitabine Plus nab-Paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol; 2011 Oct 3 [Epub ahead of print].
44. Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, et al. Stromal biology and therapy in pancreatic cancer. Gut 2011;60:861-8.
45. Chen JQ, Contreras RG, Wang R, Fernandez SV, Shoshani L, Russo IH, et al. Sodium/potassium ATPase (Nap, Kp-ATPase) and ouabain related cardiac glycosides: a new paradigm for development of anti-breast cancer drugs? Breast Cancer Res Treat 2005;96:1-15.
46. Raghavendia PB, Sreenivasan Y, Manna SK. Oleandrin induces apoptosis in human but not murine cells: dephosphorylation of Akt, expression of FasL and alteration of membrane fluidity. Mol Immunol 2007;44:2292-302. (Pubitemid 46097118)
47. Ewald B, Sampath D, Plunkett W. Nucleoside analogs: molecular mechanisms signaling cell death. Oncogene 2008;27:6522-37.
48. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase Akt pathway in human cancer. Nat Rev Cancer 2002;2:489-501. (Pubitemid 37328931)
49. Newman RA, Keondo Y, Yokoyama T, Dixon S, Cartwright C, Chan D, et al. Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Integr Cancer Ther 2007;6:354-64. (Pubitemid 350136018)
50. Wang J, Lohman GJ, Stubbe J. Enhanced subunit interactions with gemcitabine-5'-diphosphate inhibit ribonucleotide reductases. Proc Natl Acad Sci USA 2007;104:14324-9. (Pubitemid 350003260)
51. Pardo R, Lo Ré A, Archange C, Ropolo A, Papademetrio DL, Gonzalez CD, et al. Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells. Pancreatology 2010;10: 19-26.
52. Ropolo A, Grasso D, Pardo R, Sacchetti ML, Archange C, Lo Re A, et al. The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells. J Biol Chem 2007;282:37124-33.
53. Vaccaro MI. Autophagy and pancreas disease. Pancreatology 2008;8:425-9.
54. Jackson AS, Jain P, Watkins GR, Whitfield GA, Green MM, Valle J, et al. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer. Clin Oncol (R Coll Radiol) 2010;22:570-7.
55. Stokes JB, Nolan NJ, Stelow EB, Walters DM, Weiss GR, de Lange EE, et al. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Ann Surg Oncol 2011;18:619-27.
56. Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 2009;27: 5513-8.
57. Wisniewska-Jarosinska M, Sliwinski T, Kasznicki J, Kaczmarczyk D, Krupa R, Bloch K, et al. Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells. Mol Biol Rep 2011;38:3679-88.
58. Di Gennaro E, Piro G, Chianese MI, Franco R, Di Cintio A, Moccia T, et al. Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase. Br J Cancer 2010;103:1680-91.
59. Sheikh R, Walsh N, Clynes M, O'Connor RO, McDermott R. Challenges of drug resistance in the management of pancreatic cancer. Expert Rev Anticancer Ther 2010;10:1647-61.
60. Kung HJ. Targeting tyrosine kinases and autophagy in prostate cancer. Horm Cancer 2011;2:38-46.
61. Conroy T, Desseigne F, Ychou M, Ducreux M, Bouche O, Guimbaud R, et al. Randomized phase III trial comparing FOLFIRINOX (F: 5FU/leucovorin [LV], irinotecan [I], and oxaliplatin [O]) versus gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): preplanned interim analysis results of the PRODIGE 4/ACOORD 11 trial. J Clin Oncol 2010;28(May 20 Supplement):4010.
62. Tung WL, Wang Y, Gout PW, Liu DM, Gleave M, Wang Y. Use of irinotecan for treatment of small cell carcinoma of the prostate. Prostate 2011;71:675-81.
63. Yu H, Su J, Xu Y, Kang J, Li H, Zhang L, et al. p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins. Eur J Cancer 2011;47:1585-94.
64. O'Donovan TR, O'Sullivan GC, McKenna S. Induction of autophagy by drugresistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 2011;7:509-24.
65. Zhang G, Park MA, Mitchell C, Hamed H, Rahmani M, Martin AP, et al. Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation. Clin Cancer Res 2008;14:5385-99.
66. Martin AP, Park MA, Mitchell C, Walker T, Rahmani M, Thorburn A, et al. BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing. Mol Pharmacol 2009;76:327-41.
67. Naumann P, Fortunato F, Zentgraf H, Büchler MW, Herr I, Werner J. Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer. Int J Oncol 2011; 39:101-9.